Sg Americas Securities, LLC Tyme Technologies, Inc. Transaction History

Sg Americas Securities, LLC

  • $27.6 Billion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 09, 2020
SELL
$0.93 - $1.35 $33,500 - $48,629
-36,022 Closed
0 $0
Q2 2020

Jul 20, 2020
BUY
$0.97 - $1.7 $13,868 - $24,304
14,297 Added 65.81%
36,022 $48,000
Q1 2020

Apr 30, 2020
BUY
$0.9 - $1.95 $19,552 - $42,363
21,725 New
21,725 $24,000
Q4 2019

Jan 28, 2020
SELL
$1.0 - $1.49 $12,722 - $18,955
-12,722 Closed
0 $0
Q3 2019

Nov 04, 2019
BUY
$0.97 - $1.77 $12,340 - $22,517
12,722 New
12,722 $15,000
Q2 2019

Jul 29, 2019
SELL
$0.96 - $1.89 $14,778 - $29,094
-15,394 Closed
0 $0
Q1 2019

Apr 29, 2019
BUY
$1.76 - $3.73 $27,093 - $57,419
15,394 New
15,394 $27,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email